SALT LAKE CITY, May 30, 2024 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst", Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced that Jason Alger, Chief Financial Officer, and Jack Knight, Vice President of Investor Relations, will participate in the following upcoming investor conferences: The Stifel Cross Sector Insight Conference, being held in Boston, including a fireside chat on Tuesday, June 4, 2024, at 9:45am ET. T ...

Investors might want to bet on Health Catalyst (HCAT) , as earnings estimates for this company have been showing solid improvement lately. The stock has already gained solid short-term price momentum, and this trend might continue with its still improving earnings outlook. 12 Month EPS Current-Quarter Estimate Revisions The earnings estimate of $0.09 per share for the current quarter represents a change of +80% from the number reported a year ago. The Zacks Consensus Estimate for Health Catalyst has increas ...

Shares of Health Catalyst (HCAT) have gained 11.6% over the past four weeks to close the last trading session at $6.73, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $11.79 indicates a potential upside of 75.2%. The average comprises 14 short-term price targets ranging from a low of $8 to a high of $16, with a standard deviation of $2.72. While the lowest estimate indicates an ...

SALT LAKE CITY, May 21, 2024 /PRNewswire/ -- Health Catalyst, Inc. ("Health Catalyst,"Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced the launch of Health Catalyst Ignite®, a next-generation healthcare data and analytics ecosystem that combines best-in-class technologies, healthcare-specific data models, self-service tools, and industry expertise in one modern environment. Today's health systems face significant challenges in navig ...

Health Catalyst (HCAT) reported $74.72 million in revenue for the quarter ended March 2024, representing a year-over-year increase of 1.2%. EPS of $0.05 for the same period compares to $0.05 a year ago.The reported revenue compares to the Zacks Consensus Estimate of $74.81 million, representing a surprise of -0.11%. The company delivered an EPS surprise of +66.67%, with the consensus EPS estimate being $0.03.While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wal ...

Health Catalyst (HCAT) came out with quarterly earnings of $0.05 per share, beating the Zacks Consensus Estimate of $0.03 per share. This compares to earnings of $0.05 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 66.67%. A quarter ago, it was expected that this provider of data analytics for the health care industry would post a loss of $0.01 per share when it actually produced earnings of $0.02, delivering a surprise of 30 ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ________________ FORM 10-Q ________________ (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024 Or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _____ to _____ Commission File Number: 001-38993 HEALTH CATALYST, INC. (Exact name of registrant as specified in its charter ...

Health Catalyst Reports First Quarter 2024 Results SALT LAKE CITY, UT, May 9, 2024 — Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today reported financial results for the quarter ended March 31, 2024. "For the first quarter of 2024, I am pleased by our strong financial results, including total revenue of $74.7 million and Adjusted EBITDA of $3.4 million, with these results beating the mid-point of our q ...

Wall Street analysts expect Health Catalyst (HCAT) to post quarterly earnings of $0.03 per share in its upcoming report, which indicates a year-over-year decline of 40%. Revenues are expected to be $74.81 million, up 1.3% from the year-ago quarter.The consensus EPS estimate for the quarter has remained unchanged over the last 30 days. This represents how the covering analysts, as a whole, have reassessed their initial estimates during this timeframe.Prior to a company's earnings announcement, it is crucial ...

Client Engagement and Market Position - Health Catalyst has generated over 1,600 documented, client-verified improvements across clinical, financial, and operational domains, enabling substantial clinical improvements, financial savings, or operational efficiencies[36]. - Client engagement has increased as measurable improvements are delivered, leading to a broader engagement and referrals for new business[37]. - As of December 31, 2023, the company served 109 DOS Subscription Clients and over 525 other clients, primarily in the healthcare sector[38]. - The company achieved Dollar-based Retention Rates for DOS Subscription Clients of 100%, 100%, and 112% for the years ended December 31, 2023, 2022, and 2021, respectively[47]. - The company estimates its total core addressable market to include more than 1,200 healthcare organizations, indicating substantial growth opportunities[47]. - A significant portion of the company's revenue is expected to derive from the renewal of existing client contracts and sales of additional technology and services[141]. Product and Service Offerings - Health Catalyst's solution includes a cloud-based data and analytics platform, software applications, and professional services expertise tailored for healthcare organizations[18]. - The Data Operating System (DOS) platform has generated over 1,600 documented, client-verified improvements across clinical, financial, and operational domains[40]. - The company plans to continue investing in product development, particularly at the analytics applications layer of its technology stack[47]. - The company has developed an activity-based costing software application, PowerCosting, which enables CFOs and analysts to understand the true cost of clinical processes and patient outcomes[58]. - The Patient Safety Monitor application uses machine learning to predict patient safety risks, allowing clinicians to intervene proactively[58]. - The company provides a suite of population health analytics modules, including Pop Analyzer and Stratify, to support value-based care arrangements[58]. - The company’s revenue improvement solution, VitalCDM, aims to enhance operational efficiency and minimize compliance risk for hospital billing departments[62]. Team Member Engagement and Culture - The company maintains a high level of team member engagement, ranking in the 94th to 99th percentile as measured by Gallup[21]. - The company employs over 1,300 team members, with team member engagement scores consistently ranking in the 94th to 99th percentile[66][69]. - The company has received 87 recognitions as a "best place to work" from various organizations, indicating strong employee satisfaction and loyalty[69]. - The company emphasizes team member engagement as a top priority, which is believed to drive client trust and financial performance[99]. - Health Catalyst has implemented various human capital management objectives, including attracting and retaining a diverse workforce and providing opportunities for career growth[100]. - The company conducts regular team member surveys and monthly meetings to assess job satisfaction and improve retention[102]. - Health Catalyst offers market-competitive compensation, short-term bonuses, long-term equity incentives, and comprehensive benefits to its team members[103]. Financial Performance and Risks - Future financial performance is subject to various risks, including competition, technological changes, and macroeconomic challenges such as inflation and interest rates[15]. - The company’s operating model benefits from the recurring nature of its revenue, providing high revenue visibility and potential for operating leverage[41]. - The company faces intense competition in the healthcare solutions market, including from well-financed entities like Optum Analytics and IBM, which may hinder its market share[114]. - Macroeconomic challenges, including high inflation and interest rates, have adversely affected demand for the company's solutions and may lead to client bankruptcies[120]. - The company’s results of operations have historically fluctuated and may continue to do so, influenced by various external factors including macroeconomic challenges[144]. - The company recognizes technology and professional services revenue ratably over contract terms, which may delay the reflection of downturns in business in financial results[161]. - The company faces potential risks from medical malpractice claims, which could result in damage awards exceeding insurance coverage limits, adversely affecting financial condition[154]. Compliance and Regulatory Environment - The company is subject to various federal and state regulations, including those related to the corporate practice of medicine and fee-splitting laws[84]. - Compliance with evolving federal and state certification requirements is critical for maintaining the company's patient safety organization certification[85]. - The FDA regulates certain medical software, and Health Catalyst believes its marketed products are not currently classified as medical devices under FDA regulations[90]. - The company is subject to foreign regulations in countries where it operates, including the UK, India, Singapore, UAE, and Australia[95]. Technology and Cybersecurity - The DOS platform is cloud-based and primarily provided through Microsoft Azure, enhancing scalability and security[49]. - Cybersecurity risks are heightened due to reliance on internet technology and remote work, which may expose the company to potential data breaches and operational disruptions[182]. - The company’s general liability insurance may not cover all potential claims related to security breaches, exposing it to unexpected costs[186]. - The company relies on third-party vendors for Internet and telecommunications services, which increases vulnerability to service interruptions and delays[197]. - The company does not maintain redundant systems, risking extended periods of system unavailability in catastrophic events[198]. Acquisitions and Growth Strategy - The company has a track record of identifying and integrating new capabilities through acquisitions, including Medicity and Able Health[47]. - The company has acquired several businesses in recent years, including ERS in 2023, but may face challenges in integrating these acquisitions and realizing anticipated benefits[165]. - The anticipated benefits of acquisitions may not materialize, leading to potential impairment charges that could adversely affect results of operations[168]. Future Outlook and Strategic Initiatives - The company plans to hold its annual Healthcare Analytics Summit in February 2024, showcasing data-informed improvements in healthcare[70]. - The company must continue to invest in research and development to enhance existing services and introduce new applications to remain competitive[138]. - Future revenue growth may not match historical rates, with potential declines due to slower client adoption of solutions and increased competition in adjacent markets[176]. - The company faces significant uncertainty regarding the impact of the Final Rule on interoperability and information blocking, which could affect data access and market competition[188].